Indivumed Therapeutics Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
89
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$4.88M
Indivumed Therapeutics General Information
Description
Provider of target discovery services intended to advance precision oncology therapeutics. The company offers validated therapeutic targets, lead compound development, diagnostic signatures, biomarker discovery, clinical trial performance, and target out-licensing, enabling biotechnology companies to identify novel therapeutic targets grounded in native human tumor biology.
Contact Information
Website
www.indivumed.comCorporate Office
- Falkenried 88
- Building D
- 20251 Hamburg
- Germany
Corporate Office
- Falkenried 88
- Building D
- 20251 Hamburg
- Germany
Indivumed Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Debt - General | 17-Jan-2022 | $4.88M | Completed | Generating Revenue | ||
| 1. Debt - General | 08-Jan-2018 | Completed | Generating Revenue |
Indivumed Therapeutics Comparisons
Industry
Financing
Details
Indivumed Therapeutics Competitors (65)
One of Indivumed Therapeutics’s 65 competitors is Auron Therapeutics, a Venture Capital-Backed company based in Newton, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Auron Therapeutics | Venture Capital-Backed | Newton, MA | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Parion Sciences | Venture Capital-Backed | Durham, NC | ||||
| WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
| Tenax Therapeutics | Formerly VC-backed | Chapel Hill, NC |
Indivumed Therapeutics Patents
Indivumed Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260226557-A1 | Cancer subtype identifier and method for classifying tumors | Pending | 20-Dec-2024 | ||
| WO-2026132084-A2 | Cancer subtype identifier and method for classifying tumors | Pending | 20-Dec-2024 | ||
| WO-2026132084-A3 | Cancer subtype identifier and method for classifying tumors | Pending | 20-Dec-2024 | ||
| EP-4698681-A1 | Colorectal cancer subtype identifier | Pending | 20-Apr-2023 | ||
| JP-2026514729-A | Colorectal cancer subtype identifier | Pending | 20-Apr-2023 | C12Q1/6886 |
Indivumed Therapeutics Signals
Indivumed Therapeutics Investments (2)
Indivumed Therapeutics’s most recent deal was a Joint Venture with Ix Therapeutics. The deal was made on 18-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ix Therapeutics | 18-Mar-2021 | Joint Venture | Drug Discovery | ||
| Sysmex Inostics | Early Stage VC | Laboratory Services (Healthcare) |
Indivumed Therapeutics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ix Therapeutics | Hamburg, Germany | 2021 | |
| Indivutest | Hamburg, Germany | 2011 |
Indivumed Therapeutics FAQs
-
When was Indivumed Therapeutics founded?
Indivumed Therapeutics was founded in 2001.
-
Where is Indivumed Therapeutics headquartered?
Indivumed Therapeutics is headquartered in Hamburg, Germany.
-
What is the size of Indivumed Therapeutics?
Indivumed Therapeutics has 89 total employees.
-
What industry is Indivumed Therapeutics in?
Indivumed Therapeutics’s primary industry is Drug Discovery.
-
Is Indivumed Therapeutics a private or public company?
Indivumed Therapeutics is a Private company.
-
What is Indivumed Therapeutics’s current revenue?
The current revenue for Indivumed Therapeutics is .
-
How much funding has Indivumed Therapeutics raised over time?
Indivumed Therapeutics has raised $52.5M.
-
Who are Indivumed Therapeutics’s competitors?
Auron Therapeutics, Sorrento Therapeutics, Parion Sciences, WaVe Life Sciences, and Tenax Therapeutics are some of the 65 competitors of Indivumed Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process